Several cancer treatments are known to be cardiotoxic. Anthracyclines, such as doxorubicin and daunorubicin, are well-known for their potential to cause heart damage. Other chemotherapeutic agents, such as cyclophosphamide and trastuzumab (a targeted therapy), have also been implicated. Additionally, certain tyrosine kinase inhibitors, like sunitinib and imatinib, and radiation therapy, especially when targeted near the heart, can lead to cardiotoxic effects.
